insights_auto
Why is ORX down 3,65%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,84 SEK
arrow_downward
-3,65%(-0,032) 1D
16 ნოე, 15:45:55 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
295,81 მლნ.
Avg. vol.
777,72 ათ.
Volume
383,52 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
0,89 SEK
High
0,89 SEK
Low
0,82 SEK
Mkt. cap
295,81 მლნ.
Avg. vol.
777,72 ათ.
Volume
383,52 ათ.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 საათის წინ
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
Kitco
·
2 საათის წინ
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Crypto News
·
3 საათის წინ
Bitget launches rToken Earn for tokenized S&P 500, Nasdaq-100 ETFs
FXEmpire
·
1 საათის წინ
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com